Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease - Wikidata - awgldk - TriplyDB

Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease

Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease

http://www.wikidata.org/entity/Q37195103

about

Immunoregulatory networks in sickle cell alloimmunization.Hemin controls T cell polarization in sickle cell alloimmunization.Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.The sickle cell mouse lung: proinflammatory and primed for allergic inflammation.B Cells with Regulatory Function in Human Diseases Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms.Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.Immune Regulation of sickle Cell Alloimmunization.Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.Anti-CD20 Antibody Prevents Red Blood Cell Alloimmunization in a Mouse Model.Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients.Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.How I safely transfuse patients with sickle cell disease and manage delayed hemolytic transfusion reactions.

P2860

Q33667429-CE362F5C-09C2-40F7-ABD8-B9BAF91A0124 Q33797355-0F6ACABA-6846-422A-972A-37925F424BAE Q34792041-B1E5771D-E138-4614-9230-9FB6DCCA7832 Q35811966-E3C91817-A803-41F2-B1D8-61F9CDEF06D4 Q35958161-B39C85BE-6211-4119-9539-BA67A7FBDB0F Q36677543-749CE086-BCA2-45BB-BF66-D2855659993E Q38666286-6389AFCF-037C-4356-AF18-A16349A8E517 Q38792156-FC2B3C17-B782-452A-8657-22392631EFC4 Q38847491-1852FD91-55D7-4F9B-A37F-035671794ABC Q38928447-E8FBED93-AFC3-438A-AB45-5C5167F3EA24 Q40787085-15D99CD7-463E-4DBA-8DE7-C49388E60DC5 Q47621588-27852E73-12E5-4695-984A-E880AA14AF8D Q50437265-E0AFE23B-B970-4C98-9B4D-819109C01557 Q50450148-0840E7E9-5A86-473E-AF46-9F3147636ED1 Q50459485-2E5456DA-496A-4459-90FC-61FC5A1F1F8C Q53686375-1EF7FE82-CCC2-4498-B4E6-14C16D2C4177

P2860

Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease

http://www.wikidata.org/entity/Q37195103

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Regulatory B-cell compartment ...... ients with sickle cell disease

@en

Regulatory B-cell compartment ...... ents with sickle cell disease.

@nl

type

label

Regulatory B-cell compartment ...... ients with sickle cell disease

@en

Regulatory B-cell compartment ...... ents with sickle cell disease.

@nl

prefLabel

Regulatory B-cell compartment ...... ients with sickle cell disease

@en

Regulatory B-cell compartment ...... ents with sickle cell disease.

@nl

P1433

Q37195103-7F425669-14EB-4B0F-A2B1-EF1B136A8CA3

P1476

Q37195103-14B848CE-BBA7-43DE-803E-D0CBEF496892

P2093

Q37195103-15032A28-776B-403F-AD69-C855E16490A8

Q37195103-1C975DCC-B88E-4CEF-AD2C-D89E6E91D29F

Q37195103-97371934-95A7-4DC6-AF6A-4F0E74E594DC

Q37195103-9788C619-124E-4740-AD15-8BED27FEFAF5

Q37195103-D6B6E3DE-5CE9-4787-A9B6-2675CF808CDD

Q37195103-E9387917-4681-4146-8FFF-A4523F93EB5E

Q37195103-F2C2D253-A3F1-4DD4-8D1C-49EA1182DCE3

P2860

Q37195103-125F7B9A-1FDC-479D-BFBD-42F2166C0B99

Q37195103-132ADD0A-4962-44AE-9FDF-8EC3F6A6844B

Q37195103-1A815F32-EDCE-4912-AFFD-5EA39662AB6D

Q37195103-2C5BA908-7972-41E9-9440-E8BC6B5AEFF4

Q37195103-35470F20-AA2D-427A-B2BB-1E2278B7AFA1

Q37195103-384B314D-6A34-4B37-AEA1-427C326F2900

Q37195103-49028833-B29B-4685-89C3-4A2BE71F14F4

Q37195103-50C2150F-B1D4-4A20-BA4D-C8D9C2496CF9

Q37195103-566AB189-FACA-4208-AFDF-7E2C34547607

Q37195103-58DBAF9F-240F-4596-8C29-788D6F92CB93

P304

Q37195103-99C7FDD8-F849-49A4-B30B-6CE200F29E60

P31

Q37195103-CBED232F-1E8C-40C9-B16A-C83AB6A6C073

P356

Q37195103-DA706BB0-9BF0-4769-A0A1-1F08B6013A04

P433

Q37195103-3AC17F7E-462A-4DFE-A365-276E533BECF3

P478

Q37195103-06DF41D6-F671-4C78-B1B8-0A2701DE5F63

P50

Q37195103-0EDA26D9-BCB7-4A08-A24F-1C2F0D397D63

Q37195103-5B74A78C-0FD3-4FE5-A6D8-839CC6F02F48

P577

Q37195103-BDAFBDDF-D2E1-4199-BFF1-B6452062F036

P698

Q37195103-FBBE4FEB-A705-44EE-9635-D366F1924953

P921

Q37195103-D6EADC84-8FB7-442A-9F39-960CFE4FBFFF

P932

Q37195103-171CEF3A-9E14-4A3C-A0D2-71B259A78811

P356

P1433

American Journal of Hematology

P1476

Regulatory B-cell compartment ...... ients with sickle cell disease

@en

P2093

Deepa Manwani

http://www.w3.org/2001/XMLSchema#string

Hui Zhong

http://www.w3.org/2001/XMLSchema#string

Joan Uehlinger

http://www.w3.org/2001/XMLSchema#string

Karina Yazdanbakhsh

http://www.w3.org/2001/XMLSchema#string

Margaret T Lee

http://www.w3.org/2001/XMLSchema#string

Sujit Sheth

http://www.w3.org/2001/XMLSchema#string

Weili Bao

http://www.w3.org/2001/XMLSchema#string

P2860

Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents.

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

B cells regulate autoimmunity by provision of IL-10.

Current issues with blood transfusions in sickle cell disease.

Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.

Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis.

Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation

Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.

P304

736-740

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.23488

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Ljiljana Vasovic

P577

2013-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23720018

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3782095

http://www.w3.org/2001/XMLSchema#string